Durham, North Carolina — According to state and local economic development sources KBI Biopharma plans to invest $150,000,000.00 to build out 140,000 square feet of new space in Durham. The company plans to occupy the new space in Durham, on or about April 1, 2022. According to the company website KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. With each of our 300+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.

To learn more about KBI Biopharma, visit http://www.kbibiopharma.com/

Company Contact:
Dirk Lange, Chief Executive Officer
dlange@kbibiopharma.com
https://www.linkedin.com/in/dirk-t-lange-4a6722a/
919-479-9898

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved